WHAT IS THE REAL IMPACT OF DEPRESSION ON CLINICAL RESPONSE TO THERAPY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS?

被引：0
作者：
Martins, A. [1 ,2 ]
Oliveira, D. Santos [1 ,2 ,3 ]
Nicolau, R. [2 ,4 ]
Martins-Rocha, T. [1 ,2 ]
Bernardo, A. [1 ]
Pimenta, S. [1 ,2 ]
Bernardes, M. [1 ,2 ]
Costa, L. [1 ]
机构：
[1] Sao Joao Univ Hosp Ctr, Rheumatol, Porto, Portugal
[2] Univ Porto FMUP, Fac Med, Med, Porto, Portugal
[3] Univ Porto FMUP, Fac Med, CINTESIS, Porto, Portugal
[4] Ctr Hosp Tondela Viseu, Epe, Rheumatol, Viseu, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Psoriatic arthritis; bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.1101
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1129 / 1129
页数：1
相关论文
共 50 条
  • [21] Psychologic Morbidity Among Psoriatic Arthritis Patients in Remission or With Low Disease Activity A Comparison Between Biologic and Conventional Synthetic Disease-Modifying Antirheumatic Drugs
    Wohl, Yonit
    Reitblat, Olga
    Lerman, Tsahi T.
    Cohen, Ornit
    Reitblat, Tatiana
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 (06) : 260 - 264
  • [22] Biologic Disease-Modifying Antirheumatic Drugs for Preventing Radiographic Progression in Psoriatic Arthritis: A Systematic Review and Network Meta-Analysis
    Wang, Szu-Hsuan
    Yu, Chia-Ling
    Wang, Tzu-Yu
    Yang, Chung-Han
    Chi, Ching-Chi
    [J]. PHARMACEUTICS, 2022, 14 (10)
  • [23] Simultaneous Response in Several Domains in Patients with Psoriatic Disease Treated with Etanercept as Monotherapy or in Combination with Conventional Synthetic Disease-modifying Antirheumatic Drugs
    Behrens, Frank
    Meier, Lothar
    Prinz, Joerg C.
    Jobst, Juergen
    Lippe, Ralph
    Loeschmann, Peter-Andreas
    Lorenz, Hanns-Martin
    [J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (06) : 802 - 810
  • [24] Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis.: A comparative study of 270 cases
    Ujfalussy, I
    Koó, P
    Seszták, M
    Gergely, P
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2003, 62 (02): : 155 - 160
  • [25] Disease-modifying drugs (DMARDs), Psoriatic arthritis, Real-world evidence
    Song, J.
    Abe, C.
    Banefelt, J.
    Rieem-Dun, A.
    Willems, D.
    Morup, M.
    Taieb, V.
    Lindberg, I.
    Welby, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1785 - 1786
  • [26] Rationale, current state and opportunities in combining biologic disease modifying antirheumatic drugs in rheumatoid and psoriatic arthritis
    Mutlu, Melek Yalcin
    Tascilar, Koray
    Schett, Georg
    [J]. JOINT BONE SPINE, 2023, 90 (05)
  • [27] High Prevalence of Metabolic Syndrome in Patients With Psoriatic Arthritis From Northeastern Brazil Association With Traditional Cardiovascular Risk Factors and Biologic Disease-Modifying Antirheumatic Drugs
    Adeodato Ramos, Lysiane Maria
    Poti Gomes, Kirla Wagner
    de Saboia Mont'Alverne, Andrea Rocha
    Braga, Marcio Vale
    Costa Vasconcelos, Antonio Helder
    Maia Rodrigues, Carlos Ewerton
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S186 - S192
  • [28] Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic
    Best, Jennie H.
    Vlad, Steven C.
    Tominna, Lenore
    Abbass, Ibrahim
    [J]. RHEUMATOLOGY AND THERAPY, 2020, 7 (02) : 345 - 355
  • [29] Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs
    Mariangela Atteno
    Rosario Peluso
    Luisa Costa
    Stefania Padula
    Salvatore Iervolino
    Francesco Caso
    Alessandro Sanduzzi
    Ennio Lubrano
    Antonio Del Puente
    Raffaele Scarpa
    [J]. Clinical Rheumatology, 2010, 29 : 399 - 403
  • [30] Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs
    Atteno, Mariangela
    Peluso, Rosario
    Costa, Luisa
    Padula, Stefania
    Iervolino, Salvatore
    Caso, Francesco
    Sanduzzi, Alessandro
    Lubrano, Ennio
    Del Puente, Antonio
    Scarpa, Raffaele
    [J]. CLINICAL RHEUMATOLOGY, 2010, 29 (04) : 399 - 403
12345